Advisory Resource Group
- SEC CIK
- 0001764968
- Latest filing
- Jul 14, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by Advisory Resource Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 18
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −27,523−100.0% | Sold out | Holders |
| Q4 2025 | 27,523 | $1.40M | 0.2% | +5,007+22.2% | Added | Holders |
| Q3 2025 | 22,516 | $1.25M | 0.2% | +7,362+48.6% | Added | Holders |
| Q2 2025 | 15,154 | $1.05M | 0.2% | +651+4.5% | Added | Holders |
| Q1 2025 | 14,503 | $1.01M | 0.2% | +2,518+21.0% | Added | Holders |
| Q4 2024 | 11,985 | $1.03M | 0.2% | +4,544+61.1% | Added | Holders |
| Q3 2024 | 7,441 | $886.0K | 0.2% | −27−0.4% | Reduced | Holders |
| Q2 2024 | 7,468 | $1.07M | 0.2% | +151+2.1% | Added | Holders |
| Q1 2024 | 7,317 | $939.5K | 0.2% | +823+12.7% | Added | Holders |
| Q4 2023 | 6,494 | $671.8K | 0.2% | −489−7.0% | Reduced | Holders |
| Q3 2023 | 6,983 | $635.0K | 0.2% | 00.0% | UnchangedConverted for a 2-for-1 split | Holders |
| Q2 2023 | 3,478 | $562.8K | 0.2% | −325−8.5% | Reduced | Holders |
| Q1 2023 | 3,803 | $605.2K | 0.2% | −337−8.1% | Reduced | Holders |
| Q4 2022 | 4,140 | $560.3K | 0.2% | +4,140 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −2,156−100.0% | Sold out | Holders |
| Q2 2022 | 2,156 | $240.0K | 0.1% | −434−16.8% | Reduced | Holders |
| Q1 2022 | 2,590 | $288.0K | 0.1% | +199+8.3% | Added | Holders |
| Q4 2021 | 2,391 | $239.0K | 0.1% | +286+13.6% | Added | Holders |
| Q3 2021 | 2,105 | $202.0K | 0.1% | −298−12.4% | Reduced | Holders |
| Q2 2021 | 2,403 | $201.0K | 0.1% | +2,403 | New | Holders |